Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infant MenC priming schedule and injection limb randomization study
2009-016579-31Phase 4Completed
- Sponsor
- University of Oxford
- Start
- Jun 2010
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of meningococcal group C conjugate vaccine and Hib-MenC-TT in meningococcal disease, Haemophilus influenzae type b disease (Hib), pneumococcal disease and 4 more (3 arms), sponsored by University of Oxford. Started Jun 2010; status: completed.
02
Drugs
meningococcal group C conjugate vaccineHib-MenC-TT
03
Conditions
meningococcal diseaseHaemophilus influenzae type b disease (Hib)pneumococcal diseasediphtheriaTetanus
Beyond the preview
Go deeper on 2009-016579-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016579-31.